CollPlant Biotechnologies Analyst Ratings
CollPlant Biotechnologies Analyst Ratings
While ratings are subjective and will change, the latest CollPlant Biotechnologies (CLGN) rating was a reiterated with a price target of $0.00 to $11.00. The current price CollPlant Biotechnologies (CLGN) is trading at is $6.69, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/25/2023 | 64.42% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 03/30/2023 | 64.42% | HC Wainwright & Co. | $26 → $11 | Maintains | Buy |
| 02/17/2023 | 240.06% | Alliance Global Partners | → $22.75 | Initiates Coverage On | → Buy |
| 02/09/2021 | 288.64% | HC Wainwright & Co. | $13 → $26 | Maintains | Buy |
| 05/28/2020 | 94.32% | HC Wainwright & Co. | $11 → $13 | Reiterates | → Buy |
| 04/03/2020 | 64.42% | HC Wainwright & Co. | $7 → $11 | Reiterates | → Buy |
| 12/18/2018 | 4.63% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月25日 | 64.42% | HC Wainwright公司 | →$11 | 重申 | 購買→購買 |
| 03/30/2023 | 64.42% | HC Wainwright公司 | $26→$11 | 維護 | 買 |
| 02/17/2023 | 240.06% | 聯盟全球合作夥伴 | →$22.75 | 開始承保 | →購買 |
| 02/09/2021 | 288.64% | HC Wainwright公司 | $13→$26 | 維護 | 買 |
| 05/28/2020 | 94.32% | HC Wainwright公司 | $11→$13 | 重申 | →購買 |
| 04/03/2020 | 64.42% | HC Wainwright公司 | $7→$11 | 重申 | →購買 |
| 2018年12月18日 | 4.63% | HC Wainwright公司 | →$7 | 開始承保 | →購買 |
What is the target price for CollPlant Biotechnologies (CLGN)?
Collants BioTechnologies(CLGN)的目標價格是多少？
The latest price target for CollPlant Biotechnologies (NASDAQ: CLGN) was reported by HC Wainwright & Co. on August 25, 2023. The analyst firm set a price target for $11.00 expecting CLGN to rise to within 12 months (a possible 64.42% upside). 3 analyst firms have reported ratings in the last year.
科爾植物生物技術公司(納斯達克代碼：CLGN)的最新目標價是由HC Wainwright&Co.於2023年8月25日報道的。這家分析公司將目標價定為11.00美元，預計CLGN將在12個月內升至(可能上漲64.42%)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for CollPlant Biotechnologies (CLGN)?
Collants BioTechnologies(CLGN)的最新分析師評級是什麼？
The latest analyst rating for CollPlant Biotechnologies (NASDAQ: CLGN) was provided by HC Wainwright & Co., and CollPlant Biotechnologies reiterated their buy rating.
科爾植物生物技術公司(納斯達克代碼：CLGN)的最新分析師評級由HC Wainwright&Co.提供，科爾植物生物技術公司重申其買入評級。
When is the next analyst rating going to be posted or updated for CollPlant Biotechnologies (CLGN)?
CollFactory BioTechnologies(CLGN)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CollPlant Biotechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CollPlant Biotechnologies was filed on August 25, 2023 so you should expect the next rating to be made available sometime around August 25, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與CollFactory BioTechnologies的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。CollFactory BioTechnologies的上一次評級是在2023年8月25日提交的，所以你應該預計下一次評級將在2024年8月25日左右的某個時候提供。
Is the Analyst Rating CollPlant Biotechnologies (CLGN) correct?
分析師對Collants BioTechnologies(CLGN)的評級正確嗎？
While ratings are subjective and will change, the latest CollPlant Biotechnologies (CLGN) rating was a reiterated with a price target of $0.00 to $11.00. The current price CollPlant Biotechnologies (CLGN) is trading at is $6.69, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的CollFactory BioTechnologies(CLGN)評級被重申，目標價在0.00美元至11.00美元之間。CollPlants BioTechnologies(CLGN)目前的交易價格為6.69美元，在分析師的預測範圍內。
